Document Detail

Inhibition of calcineurin by cyclosporine A exerts multiple effects on human melanoma cell lines HT168 and WM35.
MedLine Citation:
PMID:  19287956     Owner:  NLM     Status:  MEDLINE    
The immunosuppressant cyclosporine A (CsA) is a specific pharmacological inhibitor of calcineurin, the Ca2+-calmodulin activated phospho-Ser/Thr-specific protein phosphatase. Although calcineurin-inhibiting compounds are applied for local treatment of psoriasis or atopic dermatitis in dermatological practice, little is known about the functions of calcineurin in epidermis-derived malignancies. We investigated the effects of CsA on two human melanoma cell lines, the metastasis forming HT168 and WM35 established from an RGP primary lesion. CsA of 2 microM lowered the enzyme activity by 50% and caused elevation in both mRNA and protein expression of calcineurin. Cell proliferation was diminished, as well as the cellular morphology and the actin organization were altered in both cell lines. CsA increased cell death moderately in both cell lines and reduced the metabolic activity of HT168 cells, but not that of WM35 cells. CsA also elevated the expressions of both Bcl-2 and ERK1/2. Fibronectin guided migration of HT168 cells was stimulated under the effect of CsA, while that of WM35 cells was reduced, moreover, HT168 cells switched from the expression of beta3 to beta1 integrin, but WM35 cells continued to express beta3. Based on our results we propose a multiple, partly malignancy-dependent role of calcineurin in these melanoma cell lines.
Tamás Juhász; Csaba Matta; Gábor Veress; Georgina Nagy; Zsolt Szíjgyártó; Zsanett Molnár; János Fodor; Róza Zákány; Pál Gergely
Related Documents :
3458526 - Cytogenetic characterization of putative human myeloblastic leukemia cell lines (ml-1, ...
1954876 - Trophoblast cell differentiation: establishment, characterization, and modulation of a ...
12080146 - Human tumor-derived genomic dna transduced into a recipient cell induces tumor-specific...
4038766 - Human renal carcinoma: characterization of five new cell lines.
3198326 - Invasiveness in vitro of mixed aggregates composed of two human mammary cell lines mcf-...
17205306 - Immunohistochemical localization of advanced glycation end-products (ages) and their re...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  International journal of oncology     Volume:  34     ISSN:  1019-6439     ISO Abbreviation:  Int. J. Oncol.     Publication Date:  2009 Apr 
Date Detail:
Created Date:  2009-03-16     Completed Date:  2009-07-20     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9306042     Medline TA:  Int J Oncol     Country:  Greece    
Other Details:
Languages:  eng     Pagination:  995-1003     Citation Subset:  IM    
Department of Anatomy, Histology and Embryology, Medical and Health Science Centre, University of Debrecen, Hungary.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Calcineurin / antagonists & inhibitors*
Calcium / chemistry,  metabolism
Calmodulin / chemistry
Cell Line, Tumor
Cell Proliferation
Cyclosporine / pharmacology*
Cytosol / metabolism
Flow Cytometry
Gene Expression Regulation, Neoplastic*
Melanoma / drug therapy*,  metabolism*
Psoriasis / metabolism
RNA, Messenger / metabolism
Reg. No./Substance:
0/Calmodulin; 0/RNA, Messenger; 59865-13-3/Cyclosporine; 7440-70-2/Calcium; EC

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Quantitative immunocytochemical profile to predict early outcome of disease in triple-negative breas...
Next Document:  Characterization of the c.190T>C missense mutation in BRCA1 codon 64 (Cys64Arg).